NVOS

Novo Integrated Sciences (NVOS)

Novo Integrated Sciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NVOS

<< 前へ 1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/11/30	22 : 00	Business Wire	Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/10/29	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/10/14	21 : 00	Business Wire	Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/09/30	21 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/09/23	21 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/09/23	21 : 00	Business Wire	Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/09/09	06 : 11	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/08/30	21 : 00	Business Wire	Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/08/18	21 : 00	Business Wire	Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/07/16	18 : 17	TipRanks	Novo Integrated Registers 129% Jump in Q3 Revenue; Shares Rise 7.4%	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/07/15	05 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/07/15	05 : 05	Business Wire	Novo Integrated Sciences Announces Third Quarter 2021 Financial Results	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/07/07	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/07/07	21 : 00	Business Wire	Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/06/29	21 : 00	Business Wire	Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/06/22	06 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/06/03	21 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/06/03	21 : 00	Business Wire	Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/05/26	21 : 00	Business Wire	Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/05/17	21 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/05/07	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/24	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/22	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/22	21 : 00	Business Wire	Novo Integrated Sciences Announces Formation of Medical Advisory Board	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/15	21 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/15	05 : 12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/15	05 : 05	Business Wire	Novo Integrated Sciences Announces Second Quarter 2021 Financial Results	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/10	05 : 21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/09	22 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NVOS	Novo Integrated Sciences Inc
2021/04/09	21 : 55	Business Wire	Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering	NASDAQ:NVOS	Novo Integrated Sciences Inc